Matthias @matt_bigscience

Delusional biopharma R&D and techno-optimist on quest for #healthspanmaxing | Avid traveler, mahjongg player, family man. de.linkedin.com/in/MatthiasEve… Hamburg, Germany Joined January 2009

Tweets

800
Followers

542
Following

659
Likes

185

Matthias @matt_bigscience

9 months ago

Congrats. @zavaindar & Team!

Zavain Dar @zavaindar

9 months ago

Congrats. @zavaindar & Team!

51 27 433 77K 94

Download Image

0 0 2 226 0

Matthias @matt_bigscience

9 months ago

Imagine the last five years without this. reddit.com/gallery/1h5ggou

0 0 0 51 0

Matthias @matt_bigscience

2 years ago

Being in there for the mission and the fun of it.

Andrew @andrewmichaelio

2 years ago

Being in there for the mission and the fun of it.

237 333 3K 3.8M 520

Download Video

0 0 1 229 0

Matthias @matt_bigscience

3 years ago

It's launch day ... with PanHunter from patient-driven disease understanding to new therapies. evotec.com/en/investor-re…

0 0 1 0 0

Just-Evotec Biologics @JustEvotecBio

3 years ago

AI has made great strides in recent years, enabling the processing of large amounts of data in a short time frame. In this publication Evotec experts review state-of-the-art #AI methods being applied to #drugdiscovery. - hubs.ly/Q019CfLM0 #researchneverstops

0 2 4 0 0

Download Image

Matthias @matt_bigscience

3 years ago

Hello world! I am excited to start my journey with @Evotec as of today - together with all my new colleagues and all our partners driving innovation for the benefit of patients across the world. Let’s make a it count!

0 0 9 0 0

Matthias @matt_bigscience

3 years ago

Today is my last day at @McKinsey. I joined out of curiosity and for the professional challenges, stayed for the people, and leave with amazing memories and deep friendships. Thank you all - onwards and upwards :)

1 0 5 0 0

Matthias @matt_bigscience

3 years ago

New paper on how harnessing advances in science and technology can deliver transformative therapies faster while reducing the socioeconomic burden of disease. #pipelinebuilding #socioeconomic #health4people mckinsey.dsmn8.com/5M4XSJexpT

0 1 1 0 0

Matthias @matt_bigscience

4 years ago

It is true. After the lab, 20 years at @McKinsey focused on innovation and R&D in life sciences across the globe - I will join @Evotec as Chief Business Officer (BD, tech, strategy) as of May 1. For now I will stay committed to my clients & mission but stay tuned, more to come.

2 0 7 0 1

Matthias @matt_bigscience

4 years ago

What would shift to net-zero by 2050 entail? New McKinsey research lays out the six defining characteristics of the net-zero transition. Watch this video to learn more, and download the full report here: mckinsey.ds8.io/banBcbQ06X mckinsey.ds8.io/J06sP7Wec-

0 0 0 0 0

Matthias @matt_bigscience

4 years ago

The roadmap towards a #data-driven enterprise by 2025 - a big theme for the years to come: mckinsey.ds8.io/0T8bejxFpc mckinsey.ds8.io/TTbA3u-ggR

0 0 0 0 0

Matthias @matt_bigscience

4 years ago

And here it is ... MIT's "10 Breakthrough Technologies 2021" ... an annual must-read to avoid missing the pace of innovation. mRNA obviously prominently featured. #Innovation #BioRevolution mckinsey.ds8.io/KFJKkWE0wq

0 0 0 0 0

Matthias @matt_bigscience

4 years ago

Citing MGI's research, WEF notes that the Bio Revolution could be an enormous boon to the economy in the decades to come. #BioRevolution mckinsey.ds8.io/cjabK2P9NK

0 0 0 0 0

Matthias @matt_bigscience

4 years ago

New article on why integration matters in evidence generation strategies in drug R&D. #Innovation mckinsey.ds8.io/x-Fcv3MK5b

0 0 0 0 0

Matthias @matt_bigscience

4 years ago

If you are curious about #TheBioRevolution - new piece on the third wave of biomaterials. Congrats and thanks to the authors! mckinsey.ds8.io/Tk-htY7uq4

0 0 0 0 0

Matthias @matt_bigscience

4 years ago

Excited about this list of 22 technologies to watch from The Economist - quite some from the bio & tech confluence-driven #TheBioRevolution - like brain interfaces, personalized nutrition and many more. mckinsey.ds8.io/6VQ1SwWKcT

0 0 1 0 0

Matthias @matt_bigscience

4 years ago

Chinese biopharma is making a mark on the global stage as the rapidly evolving regulatory landscape and maturing innovation ecosystem spur value creation - see new articles from our biotech experts in China. #Biotech #China mckinsey.ds8.io/NeCsD3G2QS

0 0 1 0 0

Matthias @matt_bigscience

4 years ago

"Scaling AI like a tech native" ... new perspective from my colleague Nayur Khan and others. Worth a read. And here is the aspiration or challenge: how to implement MLOps at scale in biotech/biopharma R&D ... making the #BioRevolution happen. mckinsey.ds8.io/n893Uq1meE